Electroencephalography (EEG) Underused Investigative Tool in Hospitals

EEG could be more widely used to identify treatable causes of common disorders in hospital patients, say researchers in Mayo Clinic Proceedings

Rochester, MN, April 1, 2013

A retrospective study of patients who had in-hospital electroencephalography (EEG) has established that EEG is a valuable tool that could be deployed more widely to identify treatable causes of impaired consciousness in the hospital setting. The study is published in the April issue of the Mayo Clinic Proceedings.

Altered mental status (AMS) and paroxysmal spells of uncertain origin are common among hospitalized patients. Impaired consciousness can sometimes be linked to metabolic or cardiac causes, but some of these spells may represent seizures or non-convulsive epilepsy, which can be detected only by electroencephalography (EEG). Although EEG is the key test in making these diagnoses, it is relatively underused in the inpatient setting owing to lack of availability and neurologic consultation at many hospitals in the United States.

In a unique analysis of non-intubated patients in a general hospital setting investigators from the Department of Neurology, University of California at San Francisco, studied hospital patients 18 years and older who had inpatient EEG for an indication of spells or altered mental status during a six-year period from January 2005. Their aim was to determine the frequency of seizures and markers of epilepsy-like activity detected by EEG.

The EEGs and reports were reviewed for ictal activity (electrographic seizures), interictal epileptiform abnormalities (abnormal EEG activity not associated with a clinical seizure), and nonepileptiform abnormalities (not specific to a particular cause).

Demographic and clinical data were gathered from electronic medical records to determine seizure predictors. Of the 1048 patients reviewed, nearly 80% had an abnormal EEG finding, with the most common abnormality being diffuse slowing, seen in 706 patients (67.4%). Seizures (ranging from a single seizure to status epilepticus) were noted in 78 patients (7.4%). Markers of seizure potential were found in 194 patients (18.5%). Epileptiform discharges were found in 130 of the 970 patients (13.4%) in whom no electrographic seizures were recorded, a finding that indicates that these patients are at increased risk for seizures.

“The present findings underscore the relatively high frequency of seizures in non-critical hospitalized patients with spells or AMS, a finding that has seemingly been underappreciated by neurologists and non-neurologists alike,” observed lead investigator John P. Betjemann, MD, Assistant Clinical Professor, UCSF School of Medicine. “Because ictal disorders are treatable, having a relatively low threshold to obtain an EEG may be critical,” he said.

EEG is a resource-intensive test so investigators also sought to identify clinical variables that are associated with positive EEG findings to help physicians determine when this test should be ordered and to guide health care systems regarding the need for EEG availability.

However many hospitals do not have access to EEG technology. “One major barrier involves a lack of trained technologists and epileptologists to perform and interpret extended (24-hour) EEG studies.…This study demonstrates that hospitals with limited resources can perform relatively brief EEGs (1-6 hours) and still identify most seizures in these non-critically ill patients,” Betjemann concluded.

In an accompanying editorial William O. Tatum, DO, Mayo Clinic, Jacksonville, FL, and Joseph I. Sirven, MD, Mayo Clinic, Scottsdale, AZ, comment, “…the importance of the article by Betjemann et al. lies in offering outcome measures using EEG in the general hospital setting. This type of information will affect care from neurologists and neurohospitalists by helping them design evidence-based monitoring and treatment protocols….The precise value of continuous EEG-facilitated diagnosis (eg, seizure detection coupled with treatment), and the resulting improvements in patient outcomes, indeed suggests that cEEG can provide a valuable ‘window to the brain’ for neurologically ill patients.”

# # #

Notes for Editors
“Diagnostic Yield of Electroencephalography in a General Inpatient Population,” by John P. Betjemann, MD; Ivy Nguyen, BS; Carlos Santos-Sanchez, MD; Vanja C. Douglas, MD; and S. Andrew Josephson, MD.DOI: http://dx.doi.org/10.1016/j.mayocp.2012.12.013

“Does Electroencephalography Provide a ‘Window to the Brain’ for the Neurologically Ill?” by William O. Tatum, DO, and Joseph I. Sirven, MD. DOI: http://dx.doi.org/10.1016/j.mayocp.2013.02.002

Both appear in Mayo Clinic Proceedings, Volume 88, Issue 4 (April 2013), published by Elsevier.

Full text of the articles is available to credentialed journalists upon request. Contact Rachael Zaleski at 215-239-3658 or mcpmedia@elsevier.com to obtain copies. Journalists wishing to set up interviews with the authors should contact John P. Betjemann at 415-206-4133 or John.Betjemann@ucfmedctr.org, or William O. Tatum at tatum.william@mayo.edu.

About Mayo Clinic Proceedings
The flagship journal of Mayo and one of the premier peer-reviewed clinical journals in general medicine, Mayo Clinic Proceedings is among the most widely read and highly cited scientific publications for physicians, with a circulation of approximately 125,000. While the Journal is sponsored by Mayo Clinic, it welcomes submissions from authors worldwide, publishing articles that focus on clinical medicine and support the professional and educational needs of its readers. www.mayoclinicproceedings.org

About Mayo Clinic
Mayo Clinic is a nonprofit worldwide leader in medical care, research, and education for people from all walks of life. For more information visit www.mayoclinic.org/about and www.mayoclinic.org/news.

About Elsevier

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey — and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact
Rachael Zaleski
Elsevier
+1 215 239 3658
mcpmedia@elsevier.com